loading page

Favipiravir-Induced Nephrotoxicity in a Patient with COVID-19: a case report
  • +1
  • Asmaa Abdelbary,
  • Ahmad Alharafsheh,
  • Afif Ahmed,
  • Abdulqadir Nashwan
Asmaa Abdelbary
Hamad Medical Corporation
Author Profile
Ahmad Alharafsheh
Hamad Medical Corporation
Author Profile
Afif Ahmed
Hamad Medical Corporation
Author Profile
Abdulqadir Nashwan
Hamad Medical Corporation
Author Profile

Abstract

This report describes a case of 45 years old male patient who tested positive for COVID-19 presented to the emergency department on March 2021 complaining of fever, cough, runny nose, and shortness of breath. The patient denied any history of nausea or diarrhea who has eventually developed favipiravir-induced nephrotoxicity.

Peer review status:ACCEPTED

18 Apr 2021Submitted to Clinical Case Reports
19 Apr 2021Submission Checks Completed
19 Apr 2021Assigned to Editor
25 Apr 2021Reviewer(s) Assigned
31 May 2021Review(s) Completed, Editorial Evaluation Pending
11 Jun 2021Editorial Decision: Revise Minor
14 Jun 20211st Revision Received
14 Jun 2021Submission Checks Completed
14 Jun 2021Assigned to Editor
14 Jun 2021Review(s) Completed, Editorial Evaluation Pending
15 Jun 2021Editorial Decision: Accept